AI-Assisted Decision-Making for End-Stage Organ Failure: Opportunities and Ethical Concerns

Area of Science:

• Medical Informatics
• Artificial Intelligence in Healthcare
• Clinical Decision Support

Background:

• End-stage organ failure presents complex treatment choices, including medical management, transplantation, mechanical support, and palliative care.
• Current healthcare practices require robust data analysis to inform patient care pathways.

Purpose of the Study:

• To discuss current applications of artificial intelligence (AI) in guiding clinical decisions for patients with end-stage organ failure.
• To outline AI's potential in risk stratification, patient selection, and outcome prediction, especially in transplantation.
• To address the need for data standardization, algorithm validation, and ethical considerations for AI implementation.

Main Methods:

• Analysis of large datasets from electronic health records, imaging, and patient-reported outcomes.
• Review of AI applications in healthcare decision-making for organ failure.
• Examination of ethical considerations and patient perspectives on AI in clinical settings.

Main Results:

• AI can forecast long-term survival and quality of life, aiding in treatment strategy modification.
• AI facilitates "alignment" of treatment recommendations with patient values, promoting patient-centered outcomes.
• Standardized data, rigorous validation, and transparent algorithms are crucial to mitigate bias and ensure equitable care.

Conclusions:

• Successful AI integration in organ failure care necessitates multidisciplinary collaboration, stakeholder engagement, and user-friendly design.
• AI can serve as a practical decision-support tool, complementing clinical expertise and shared decision-making.
• Addressing ethical concerns related to data privacy, equitable access, and the human element is vital for patient trust and optimal outcomes.